Announcements Trials
Browse Landscape

Phase

Phase 2 154Phase 1 49Phase 3 41Phase 1/2 29Phase 2/3 5Phase NA 3Phase 4 3Phase EARLY_PHASE1 1

Status

Unknown 19Completed 16Recruiting 8Active not recruiting 8Terminated 5Not yet recruiting 2Withdrawn 1

Sponsor Class

INDUSTRY 3OTHER 1NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 4Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Recurrence 1Prostatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Advanced Non-small Cell Lung Cancer 1

Interventions

Carboplatin 9Paclitaxel 8Gemcitabine 8Cisplatin 8Cyclophosphamide 7Fluorouracil 6Docetaxel 5Capecitabine 5Granulocyte Colony-Stimulating Factor 4Etoposide 4Vinorelbine 3Stem Cell Transplantation 3Radiotherapy 3Pemetrexed 3Melphalan 3Leucovorin 3Filgrastim 3Erlotinib Hydrochloride 3Bone Marrow Transplantation 3Bevacizumab 3umbralisib 2ublituximab 2pembrolizumab 2peginterferon alfa-2b 2fludarabine 2Whole-Body Irradiation 2Trastuzumab 2Transplantation, Homologous 2Surveys and Questionnaires 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Terminated × Docetaxel × Clear all
NCT05001724 2023-04-25

KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Phase 2/3 Terminated
16 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

NCT01774578 2020-05-28

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Lumos Pharma

Phase 2/3 Terminated
135 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT02326285 2018-01-23

NeoIntercal

AIO-Studien-gGmbH

Phase 2/3 Terminated
1 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01603420 2016-03-14

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Proton Collaborative Group

Phase 2/3 Terminated
2 enrolled 8 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT01348126 2015-11-05

GALAXY

Synta Pharmaceuticals Corp.

Phase 2/3 Terminated
385 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡